Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
US6028071 | ACROTECH | Purified compositions of 10-propargyl-10-deazaaminopterin and methods of using same in the treatment of tumors |
Jul, 2022
(1 year, 8 months ago) | |
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8299078 | ACROTECH | Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin |
May, 2025
(1 year, 2 months from now) | |
US7622470 | ACROTECH | Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin |
May, 2025
(1 year, 2 months from now) |
Market Authorisation Date: 24 September, 2009
Treatment: Treatment of patients with relapsed or refractory peripheral t-cell lymphoma
Dosage: SOLUTION;INTRAVENOUS